Genomtec

Genomtec EPS

The Earnings per Share (EPS) of Genomtec (GMT.WA) as of Nov 10, 2026 is -0.69 PLN. In the previous year, Earnings per Share (EPS) was -0.84 PLN — a change of -17.68% (higher).

EPS

-0.69PLN

YoY

-17.68%

Last updated:

Earnings per Share (EPS) of Genomtec is 2025 -0.69 PLN. Earnings per Share (EPS) of Genomtec was 2024 -0.84 PLN. It decreases by -17.68% higher compared to the previous year.

The Genomtec EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-0.04 PLN
Jan 1, 2019
-0.18 PLN
Jan 1, 2020
-1.34 PLN
Jan 1, 2021
-0.87 PLN
Jan 1, 2022
-1.27 PLN
Jan 1, 2023
-0.74 PLN
Jan 1, 2024
-0.84 PLN
Jan 1, 2025
-0.69 PLN
The Genomtec EPS history
YEAREPSYoY
-0.69PLN-17.68%
-0.84PLN+14.40%
-0.74PLN-42.28%
-1.27PLN+46.06%
-0.87PLN-34.96%
-1.34PLN+656.08%
-0.18PLN+307.45%
-0.04PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genomtec Stock analysis

What does Genomtec do? Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments. Genomtec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomtec stock

Earnings per Share (EPS) of Genomtec is -0.69 PLN in 2025.

Earnings per Share (EPS) of Genomtec changed from -0.84 PLN to -0.69 PLN, representing a -17.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Genomtec since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Genomtec

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genomtec